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Abstract
The purpose of this evidence-based project was to provide patient education in
order to increase human papillomavirus (HPV) vaccination rates in military women.
Despite the availability of a vaccine, HPV continues to be the most common sexually
transmitted infection (STI) in the United States. The goal of this program was to increase
patient knowledge and HPV vaccination rates by providing education and a verbal
recommendation for vaccination during regularly scheduled well-woman exams (WWE).
The project resulted in a 65% increase in vaccination rates, raising the pre-program
vaccination rate of 55% to a post-intervention vaccine percentage of 91%. The results
demonstrate the importance of patient education and provider recommendation in vaccine
acceptance.
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Background
Sexually transmitted infections (STIs) are a persistent and costly health care
burden in the United States. According to the Centers for Disease Control and Prevention
(CDC), close to 20 million new STIs occur in the United States each year; with half of
these occurring among our nation’s youth ages 15-24. Annual health care costs associated
with STI treatment are about $16.4 billion (CDC, 2013). Human Papillomavirus (HPV)
infection is the most common STI in the United States despite the availability of a
vaccine. Vaccines such as Gardasil are the safest and most effective way to prevent
cervical cancer and other HPV-related problems (CDC, 2013). While there is no cure for
the virus, significant reductions in new HPV infections and reinfection rates are possible
with vaccine administration.
The Human Papillomavirus is extremely common. In fact, the American Cancer
Society (ACS) compares genital HPV incidence to that of the common cold. They go on
to state “nearly all sexually-active men and women get HPV at some point in their lives.
This is true even for people who only have sex with one person in their lifetime” (ACS,
2014). This is because most cases of HPV are asymptomatic, people are unaware they are
infected, and over 90% of the time the body’s immune system will clear the virus on its
own within two years (ACS, 2014). However, HPV remains the biggest risk factor for
cervical cancer, and persistent infections with high-risk HPV subtypes (16 and 18) are
associated with 99% of all cervical cancers (CDC, 2012).
So, how big could HPV’s impact possibly be? In 2008 there were approximately
14.1 million newly diagnosed cases of HPV, resulting in a prevalence of 79.1 million
cases (CDC, 2013). Unfortunately, HPV has other associated complications beyond
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cervical cancer. HPV accounts for 90% of anal cancers, 12% of oral and pharyngeal
cancers, and 40% of vulvar, and vaginal and/or penile cancers (CDC, 2012). Another
complication of HPV is anogenital warts caused by subtypes 6 and 11. An estimated
360,000 Americans contract genital warts each year (ACS, 2015). These statistics are
staggering and demonstrate the urgent need for intervention.
The population of interest for this specific evidence-based program was U.S.
Navy active duty servicewomen ages 17-26 stationed in San Diego, California. Thus, it is
important to examine HPV prevalence in this specific group of women as well.
According to Goyal, Mattocks, and Saddler (2012), there are significantly higher rates of
STIs, HPV, and cervical dysplasia among young servicewomen than in civilian women.
They believe this is because active duty servicewomen “tend to be young and unmarried
and belong to racial and ethnic minority groups” associated with increased risk (Goyal et
al., 2012, p. 1155). Goyal et al. (2012) went on to state:
Although data are limited, the prevalence of HPV infection may also be higher
among women in the military compared to those in the general population. In
studies among active duty servicewomen seeking care at an Army Medical Center
STI screening clinic, prevalence of any HPV type ranged between 36% and
51%,48,49 which is far higher than in the general population of U.S. women (27%,
95% confidence interval [CI] 23%-31%), but similar to that found in U.S. women
20–24 years old (45%, (95% CI 36%-55%). (p. 1157)
In another study, Shen-Gunther, Shank, and Ta (2011) examined HPV vaccination rates
among different groups of patients at Naval Medical Center San Diego (NMCSD). The
study looked at vaccine initiation and completion rates in a large group of 5,088 patients
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and found that the least adherent group of patients was active duty service members.
Although the vaccine is a covered benefit provided by TRICARE, only 16% of active
duty servicewomen completed the vaccination series compared to 43% of dependent
daughters and 21% of dependent wives. These results indicate that there is a problem
with the system and a definite need for improvement in HPV education and vaccination.
Intended Improvement
HPV is a rapidly spreading problem and will continue to be so without adequate
patient education. Thus, educating and informing patients about HPV and the HPV
vaccine is crucial. By giving patients knowledge, we can empower them to take control
of their healthcare and pass on the information to others. Thus, the clinical objective for
this evidence-based project was to provide patient education about HPV and ways to
prevent/minimize its negative effects. The expected outcome was improved HPV
vaccination rates.
Setting
The project was initiated at a southern Californian Naval Medical Facility madeup of a large multi-specialty inpatient hospital along with 10 branch clinics for military
members and their families. The program took place at one of the branch clinics
designated for active duty service members only. The program focused specifically on
well women’s exams (WWEs) performed by a designated female nurse practitioner in the
clinic. The clinical site has a large number of female patients in the targeted age range
(17-26 years) that was easily accessible during their regularly scheduled WWEs. The
program involved providing face-to-face patient education about HPV with educational
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handouts and a specific provider recommendation for vaccination. The HPV vaccine was
readily available, cost free and on-site after the visit.
Study Question
The project was designed to answer the following question: Does an educational
HPV intervention result in an increased rate of HPV vaccination among U.S. Navy active
duty females? With HPV incidence rates continually increasing, this is an area in which
nurse practitioners can really make a significant impact and play a key role in
intervention for individual patients, as well as the general public health.
Conceptual Model
This particular evidence-based project was implemented using the Iowa Model for
guidance. The Iowa Model of EBP was selected because it places an emphasis on
visualizing the healthcare system as a whole and identifies several steps to assist and
guide the practitioner in the EBP process. The model is broadly applicable and a variety
of health care disciplines can utilize and reproduce the program in their settings. For this
particular project, the identified problem and/or trigger was low HPV vaccination rates.
Ethical Issues
Prior to implementation, project approval was obtained from the University of
San Diego’s (USD) Institutional Review Board (IRB) with permission to disseminate deidentified clinical findings. The project was also reviewed by the Regional Director of
Nursing Research for the Navy Medicine West region and was approved as a quality
improvement project.
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Intervention Implementation
The intervention included face-to-face patient education, providing an educational
handout, and giving a verbal recommendation for the HPV vaccine during regularly
scheduled well-woman exams (WWEs). Patients checked-in for their regularly scheduled
WWE and completed the women’s health intake form (which included a question about
HPV vaccination status) prior to seeing the nurse practitioner. The nurse practitioner then
completed the WWE and took time during each visit for patient education and health
promotion. Patient education time was specifically dedicated to discussing HPV and the
HPV vaccine. During this time, the practitioner provided an educational handout,
answered any questions the patient had, emphasized the importance of the vaccine, and
provided a verbal recommendation for vaccination. If interested in receiving the vaccine,
the patient was then escorted directly to the immunization clinic (located on-site), where
the vaccine was administered. The patient was given a magnet with the date for the next
vaccination in the series. The practitioner then completed her documentation in the
medical record and HPV vaccination was recorded.
Evaluation Plan
The program was monitored and evaluated through chart reviews via an electronic
medical record (EMR) system. Chart reviews were conducted prior to beginning the
program to collect pre-program data, during the program, and upon completion. Charts
were screened for the HPV vaccination code and to see if the HPV vaccine had been
documented. Patient follow-up was completed via email and phone call if they had not
received the vaccine during the visit. Upon completion of the program, data were
compiled and a vaccination percentage was generated.
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Results
The goal of this program was to increase patient knowledge and HPV
vaccinations rates by 20% from baseline, which was achieved and exceeded. The preprogram vaccination rate was 55% and the post-intervention vaccination percentage
increased to 91%, a 65% increase in vaccination rates. Throughout the 4-month program,
103 eligible patients were identified as needing the HPV vaccination and out of those, 94
patients were then vaccinated. Also, 100% of the patients seen during the program’s
entirety received HPV education and a recommendation for vaccination if eligible.
Discussion
The Human Papillomavirus is the most common sexually transmitted infection in
the United States, yet public knowledge and vaccination rates remain low. Thus, this
program set out to increase HPV awareness and increase vaccination rates among active
duty servicewomen. The results of the program were impressive and in only 4 months, a
65% increase in vaccination rates was seen. By providing patients with HPV education
and recommending vaccination, the program created a new average vaccination rate of
91% of eligible patients, up from the previous baseline of 55%.
Another current organization encouraging HPV vaccination is the U.S.
Department of Health and Human Services’ (USDHHS), and Healthy People 2020
(HP2020) objectives seek to increase routine HPV vaccination coverage for adolescents.
Immunization and Infectious Disease (IID) objectives 11.4 and 11.5 outline goals to
increase HPV vaccination coverage for females (IID-11.4) and males (IID-11.5) ages 1315 to 80% (USDHHS, 2015). These target goals are important; however they only cover
a specific age range and do not cover those females and males who were not vaccinated
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as adolescents. There are no benchmark goals for older adolescents or young adults even
though the Gardasil vaccine is approved for females and males ages 9-26. This evidencebased program in military servicewomen exceeded the HP2020 benchmark vaccination
goal of 80% for ages 13-15 years and demonstrated the importance of continuing to
educate about HPV and encourage vaccination among older adolescents and young
adults.
The program results suggest that education about HPV will improve vaccination
rates. Thus, if health care providers educate patients, parents, and society about HPV, we
may see an increase in vaccination. One of the main arguments against vaccination is a
parental concern that it promotes sexual activity at a younger age. A recent study done by
Jena, Goldman, & Seabury (2015), found that HPV vaccination was not associated with
increased STI rates in a large cohort of females ages 12-18, suggesting that HPV
vaccination is unlikely to cause unsafe sexual practices (Jena et al., 2015). Studies such
as this one and evidence found from this project can be utilized by health care providers
to have informed conversations with patients and parents about HPV to decrease
concerns about vaccination.
In conclusion, these results demonstrate the importance of patient and provider
education about HPV and the need for vaccination recommendations from health care
providers. Future evidence-based projects should replicate this program in other clinical
sites to improve vaccination rates and increase awareness.
Conclusions and Implications
HPV is a rapidly spreading problem and will continue to be so without accurate
patient education and vaccine recommendations from health care providers. By supplying
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patients with knowledge, we can empower them to take control of their own health and
inspire them to pass on their learned experience to others. Health care professionals play
a key role in the patient education process and research has linked patient education and
vaccine recommendations to increased acceptance of HPV vaccine. Cervical cancer is a
preventable disease; together we can make a difference.
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Figure 1. Number of patients vaccinated. This figure illustrates the total number of patients seen and
percentage of those patients opting to be vaccinated
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Project Purpose: The purpose of the project was to implement Human Papillomavirus
(HPV) patient education during every well woman exam (WWE) to improve patient
knowledge and HPV vaccination rates in military women aged 18-26 years.

Background: The Human Papillomavirus (HPV) has been identified as the biggest risk
factor for cervical cancer and, despite the availability of a vaccine; HPV continues to be
the most common STI in the U. S. (American Cancer Society, 2013). Approximately 79
million Americans are currently infected with HPV, and 14 million individuals will
become infected annually, leading to more than 10,000 cases of cervical cancer each year
(Centers for Disease Control and Prevention, 2014). Most cases of HPV are
asymptomatic and people are unaware they are infected; thus, patient education and
vaccination are key elements to battling the problem. Significant reductions in new HPV
infections and reinfection rates are possible with patient education and vaccine
recommendation by health care providers.
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Project Plan: The health care provider responsible for all women’s health visits in an
active duty military treatment facility provided patient education during regularly
scheduled annual and/or initial well woman exams. Patients received an educational
handout and a verbal recommendation for the HPV vaccine. Immunizations were
provided at the close of the visit, if desired. Project effectiveness was evaluated based on
changes in HPV immunization rates before and after the project.

Outcomes: The goal of this program was to increase patient knowledge and HPV
vaccination rates by providing education and a verbal recommendation for vaccination
during regularly scheduled well-woman exams (WWE). The project resulted in a 65%
increase in vaccination rates, raising the pre-program vaccination rate of 55% to a postintervention vaccine percentage of 91%.

Conclusions: The results of this evidence-based practice project demonstrate the
importance of patient education and provider recommendation in vaccine acceptance.
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• Nearly every sexually active person will acquire HPV at some
point in their lives (ACS, 2013)
• HPV is the biggest risk factor for cervical cancer (CDC, 2012)
• Vaccines such as Gardasil are currently considered one of the
safest and most effective ways to prevent cervical cancer and
other HPV related complications (CDC, 2013)
• Educational interventions to increase HPV awareness and
vaccination help to boost vaccination rates (Kester, 2014)
• HPV vaccine uptake and acceptability increased when patients
were given education and a recommendation for vaccination
from their health care provider (Brewer & Fazekas, 2007)
• Patients were 5 times more likely to receive the HPV vaccine if a
recommendation was given by their health care provider versus
those who did not receive a recommendation (Ylitalo, Lee, &
Mehta, 2013)
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• Based on the results of this program, patient education
and health care provider recommendation for HPV
vaccination increases HPV vaccination rates
• The intervention utilized in this program should be
continued and implemented in similar clinical settings
• Vaccinating women and men against HPV could
decrease HPV infection rates, re-infection rates, and
cervical cancer incidence
• This program demonstrates the importance of patient
education and provider awareness about HPV
• HPV vaccines could potentially decrease health care
spending on HPV and HPV related complications

CONCLUSIONS/IMPLICATIONS FOR
CLINICAL PRACTICE

N=103

• The goal of this program was to increase patient
knowledge and HPV vaccinations rates by 20%
from baseline which was achieved
• The average pre-data vaccination percentage was
55% and the average post-intervention vaccination
percentage was 91%
• Out of 103 eligible patients, 94 of them were
vaccinated
• 100% of patients received HPV education and a
recommendation for vaccination if eligible
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• The purpose of this IRB approved evidence-based
quality improvement project was to implement Human
Papillomavirus (HPV) patient education during every
well woman exam (WWE) to improve patient
knowledge and HPV vaccination rates in military
women aged 18-26 years

AIM/PURPOSE

• The Human Papillomavirus (HPV) is the most common
sexually transmitted disease in the U.S., despite the
availability of a vaccine (American Cancer Society,
2013)
• 79 million Americans are currently infected with HPV,
14 million individuals will become infected annually,
leading to more than 10,000 cases of cervical cancer
each year (CDC, 2013)
• Research demonstrates that young military
servicewomen have significantly higher rates of STIs,
HPV, and cervical dysplasia
• A U.S. Army medical center STI clinic found that HPV
rates in service women ranged from 36-51%, which is
higher than the U.S. general population (Goyal,
Mattocks, & Saddler, 2012)
• Program took place at a southern California Naval
Branch Health Clinic providing care to a large
population of active duty servicewomen in the targeted
age group of (18-26) years old
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Background
• HPV is the most common sexually
transmitted disease in the U.S.
• 79 million Americans currently infected

(American Cancer Society, 2014)

o 14 million new cases/year (CDC, 2013)

• HPV is biggest risk factor for cervical cancer
(CDC, 2012)

• Studies have found military servicewomen
having higher rates of STIs, HPV, and
cervical dysplasia
(Goyal, Mattocks, & Saddler, 2012)
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Background
• Increasing vaccination rates is nationally recognized by HP2020
– Immunization and Infectious Disease (IID)
Objective IID-11: Increase routine vaccination coverage
levels for adolescents
• IID-11.4: Increase the vaccination coverage level of 3
doses of human papillomavirus (HPV) vaccine for
females by age 13 to 15 years to 80%
• IID-11.5: Increase the vaccination coverage level of 3
doses of human papillomavirus (HPV) vaccine for males
by age 13 to 15 years to 80%
– NO BENCHMARK FOR OLDER ADOLESCENTS OR
YOUNG ADULTS

Is this clinically relevant?
• Studies have found military servicewomen having
higher rates of STIs, HPV, and cervical dysplasia
• Baseline vaccination rates ranged from 48-67%
(Average 55%)
– BELOW HP2020 BENCHMARK
– Area for improvement
– Potential to:
•
•
•
•
•

Increase patient knowledge/awareness
Improve health outcomes
Empower patients to take control of their health care
Reduce HPV infections and complication rates
Cost Savings
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Practice Innovation
• HPV patient education during all
regularly scheduled well women’s exams
(WWEs) and educational handouts
were provided
• HCP provided verbal recommendation
for HPV vaccine
• Escorted patients to immunization clinic
immediately after visit if vaccination
desired

Cost Benefit Analysis
• Costs:
– Provider Salary (Covered by DON)
– Paper& ink for handouts (Covered by DON)
– Gardasil Vaccine (Covered by DON)

• Benefits:
! Increase health outcomes
! Reduce HPV infection and complication rates
! DECREASE CERVICAL CANCER
! Decrease visits
! Cost savings
o Vaccine vs. Cancer Tx
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•

•

•
•
•

Goal was to increase
baseline vaccination
percentage by 20%
Increased average
vaccination
percentage to 91%
(65% increase)
HIGHER THAN
HP2020 GOAL
103 patients eligible,
94 vaccinated
100% of patients
received HPV
education

Outcomes
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HPV Vaccination Rates
Pre-Intervention:

Post-Intervention:

Feb 2014- 50%

Sep 2014- 82%

Mar 2014- 48%

Oct 2014- 91%

Apr 2014- 67%

Nov 2014- 93%

May 2014- 55%

Dec 2014- 100%

Average: 55%

Average: 91%

33	
  
	
  

Conclusions & Implications
for Clinical Practice
• HPV education and HCP recommendation
INCREASE vaccination rates
• Educational intervention could potentially
decrease HPV infection and complications
• Educational intervention with vaccination could
potentially save the Navy millions of dollars
• Providers need to be educated!
• Intervention should be implemented in similar
clinics

Barriers & Lessons Learned
• Transient population (deployments, change of
duty station) makes follow-up difficult
• Thus PATIENT EDUCATION IS KEY
• Provider Turnover/deployments
• Ensuring vaccination documentation in EMR
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Questions, Comments,
Concerns, Compliments?
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